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Adrian O’Callaghan, MD,a and James Bena, MS,c Cleveland, Ohio
Objective: Endovascular aneurysm repair (EVAR) will fail over time in a percentage of patients. Mechanical failure of the
device, progression of aortic disease, or interface complications between the device and the native vasculature may
contribute. Our aimwas to evaluate the role of fenestrated and branched endografts as treatment options for failed devices.
Methods: Between January 2001 and June 2013, 970 patients were enrolled into a physician-sponsored investigational
device exemption (PSIDE) study and treated with a fenestrated/branched endograft. All patients treated for nonurgent
proximal neck failure of an infrarenal endoprosthesis previously implanted during EVAR comprised the study group.
Patients treated for a primary aneurysm within the PSIDE were evaluated as a comparison group to identify preoperative
risk factors for failure. A retrospective review was undertaken to determine the details of the initial EVAR, whereas the
prospective PSIDE database was used to assess outcomes of secondary treatment. Three-dimensional imaging techniques
were used to deﬁne all morphologic measurements. Statistical analysis included comparisons between categoric variables
with the c2 test and between continuous variables with the Wilcoxon rank sum test between patients with late failures and
those with native aortic repair. Kaplan-Meier curves were used to analyze overall survival.
Results: Of 970 patients enrolled in the PSIDE, 54 (5.6%) had late failure of a prior endograft. Fenestrated/branched
devices were used to address the failure in each patient. The etiology of failure was related to a proximal neck issue in all
patients: type Ia endoleak in 38, stent migration in 18, neck degeneration in 28, or some combination of these factors.
The endovascular rescue procedure took place a mean of 61 months after the primary procedure. The mean aneurysm
diameter at reintervention was 67 mm. Patients requiring a secondary fenestrated procedure were younger at the time of
their primary intervention (P [ .039) and were more likely to have a history of chronic renal insufﬁciency (P [ .05)
compared with other patients in the PSIDE. Technical success rate in the study group was 85% (44 of 52). Successful
stenting was achieved in 71 of 77 (92%) target vessels. Thirty-day mortality was 3.8% (two of 52). Fluoroscopy dose and
operating time were longer in the rescue group (P[ .07) than in the control group (P[ .008). Secondary interventions
were required in 36.5% (19 of 52) of patients.
Conclusions: Our series demonstrates the risk for late failure after EVAR is greater in patients who are younger and have
chronic renal impairment at the time of implantation. Branched and fenestrated repair after failed EVAR is more complex
than repair in the native aorta. More research is needed to identify patients at higher risk of failure after EVAR to prevent
the need for rescue in the future. (J Vasc Surg 2014;59:1479-87.)Endovascular aneurysm repair (EVAR) is now>20 years
old and is a technique that has revolutionized the care of
patients with aneurysmal disease by decreasing perioperative
and midterm risks compared with open surgical repair
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failure to improve future outcomes is critical.5
Failure of aneurysm repair can be caused by device fail-
ure or progression of aortic disease. The inability to treat
the underlying cause of vessel wall degeneration relegates
current techniques of aneurysm repair to be palliative
rather than curative. Therefore, given an inﬁnite lifespan,
most patients will likely develop aneurysms in continuity
with proximal or distal aspects of the repair. In contrast,
failure may occur as a result of the device, inaccurate im-
plantation, or poor patient selection. Device failure can
manifest as material fatigue or failure of the integrity of
modular components over time. Failure at the interface
between the device and arterial wall is a manifestation of
the disease, the device, and the initial repair strategy with
respect to the proximal or distal extent of the coverage.
Irrespective of the mode of failure, the initial type of repair
will have considerable implications on the outcome of sec-
ondary procedures.1479
Fig 1. Conﬁguration of the internal limb used for endovascular repair of a short-bodied device.
JOURNAL OF VASCULAR SURGERY
1480 Martin et al June 2014Aortic repair failure may be treated with OSR, endo-
vascular repair, or medical palliation. Determining the
most appropriate strategy involves assessing the aortic
morphology, the available interventional options, and the
comorbidities at the time of failure. We have previously
published on the surgical explantation of endovascular
grafts as well as on the endovascular conversion of OSR
in the setting of late proximal neck failure.6,7 This report
describes the use of fenestrated and branched endovascular
grafts to address late failure of the proximal sealing and ﬁx-
ation zone of other infrarenal endovascular devices.METHODS
All patients who participated in this study signed a con-
sent approved by the Investigational Review Board (Na-
tional Institutes of Health study number NCT00583050).
Inclusion criteria. Between January 2001 and June
2013, data were collected prospectively on 970 patients
enrolled in a physician-sponsored investigational device
(PSIDE) study using a Zenith Fenestrated or Branched
device (Cook Inc, Bloomington, Ind). Excluded from the
detailed analysis were 27 patients who underwent emer-
gent repairs. All other patients treated for late proximal
failure of a prior EVAR were further analyzed. Patients
treated for a primary aneurysm within the PSIDE were
evaluated as a comparison group to identify preoperative
risk factors for failure. Late failure was deﬁned as any or all
of the development of a proximal (type Ia) endoleak,
clinically signiﬁcant device migration, or the development
of an aneurysm >5 cm in continuity with the initial repair.
Patients were considered to be at high risk for OSR
as determined by physiologic or anatomic characteristics,
or both, as reported previously.8,9 Follow-up included
computed tomography (CT) scan, visceral artery duplex ul-
trasound imaging, and laboratory studies #1 month of the
procedure, and annually thereafter unless more frequent
monitoring was indicated. Clinical and imaging data werereported in accordance with the EVAR reporting stan-
dards, except where noted otherwise.10,11
Device design. Devices were designed akin to previous
descriptions, with some important deviations for proximal
and distal sealing zones.9,12 For the proximal neck, fenes-
trated and branched devices were used when the neck
was <10 mm or in the setting of an aneurysm involving
visceral arteries. For the distal landing zone, the distance
between the lowest renal artery and the ﬂow divider of the
implanted endograft was critical to the strategy of the
rescue repair. When a long-body graft (>6 cm) had been
used (Zenith, Ancure [Guidant, Indianapolis, Ind], or
Endologix [Endologix, Irvine, Calif]), there was substantial
overlap that allowed the distal design of the fenestrated/
branched device to be a tube graft matched to the initial
EVAR graft above the ﬂow divider. In such cases, the distal
end of the fenestrated graft was planned such that the distal
portion was larger than the initial endograft diameter,
obviating the need for a bifurcated section. Shorter-body
infrarenal endografts required markedly more complicated
designs in which the fenestrations and endograft bifurca-
tion were incorporated into a single device with an internal
limb or a bifurcated piece with an internal limb was used.
The internal contralateral limb is an alternative to the
standard contralateral limb where the ﬁxation is above the
ﬂow divider rather than below it (Fig 1).
Data collection and image interpretation. Imaging
studies performed immediately before the endovascular
rescue were assessed in an attempt to establish the cause of
failure as well as a rescue strategy. All CT studies were
analyzed using Intuition software (Terarecon, San Mateo,
Calif). Centerline-of-ﬂow analyses were used to establish
lengthmeasurements, and orthogonal projectionswere used
to determine diameters.13 Operative reports andCT scans at
the time of the initial repair (when available) were analyzed.
Deﬁnitions. Repair types were deﬁned as previously
reported.14 Technical success was deﬁned by implanta-
tion, with patency of all intended branches, absence of
Table I. Comparison of patient characteristics between
the late failure group and the patients who had
endovascular aneurysm repair (EVAR) as their primary
repair
Variable
Endovascular
rescue
(n ¼ 52),
No. (%)
Primary EVAR
intervention
(n ¼ 891),
No. (%) P
Mean age at ﬁrst
procedure 6 SD, years
72.3 6 7.7 74.4 6 8.0 .039
Etiology
Atherosclerosis 52 (100) 887 (99) .99
Dissection 0 3 (1)
Miscellaneous 0 2 (0.2)
Male sex 45 (86.5) 698 (78.3) .16
Smoking 43 (82.7) 767 (86.1) .49
COPD 14 (27) 284 (32) .46
Coronary artery disease 36 (69) 518 (58) .11
Hypertension 47 (90) 753 (84.5) .25
Hyperlipidemia 30 (59) 515 (58) .89
Diabetes 8 (15) 165 (18) .57
Renal insufﬁciency 15 (29) 160 (18) .05
Peripheral artery disease 7 (13.5) 71 (8) .16
Family history of aneurysms 5 (10) 144 (16) .21
COPD, Chronic obstructive pulmonary disease; SD, standard deviation.
Table II. Primary endografts
Type of endograft No.
Zenitha 19
AneuRxb 15
Talentb 6
Gorec 5
Ancured 4
Endologixe 2
Aorﬁxf 1
aCook Medical, Bloomington, Ind.
bMedtronic, Minneapolis, Minn.
cW.L. Gore and Associates, Flagstaff, Ariz.
dGuidant, Indianapolis, Ind.
eEndologix, Irvine, Calif.
fLombard Medical Technologies PLC, Oxfordshire, UK.
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survival through 24 hours. Renal insufﬁciency was a
decrease in the glomerular ﬁltration rate of >30% on two
consecutive readings or a renal event requiring interven-
tion. Dialysis was considered temporary if required
for <30 days. Myocardial infarction was deﬁned by the
latest consensus document.15 Respiratory failure was
deﬁned as patients requiring mechanical ventilation for
>48 hours. Chronic obstructive pulmonary disease was
classiﬁed in accordance with the Global Initiative for
Chronic Obstructive Lung Disease (GOLD) criteria.16
Statistical analysis. Categoric factors are described
overall and by group using frequencies and percentages,
and continuous measures are described using means, stan-
dard deviations (SDs), and percentiles. Comparisons of
groups were performed using Pearson c2 tests or Fisher
exact tests for categoric factors, Wilcoxon rank sum tests
for continuous measures because distributions were not
normal, and Kaplan-Meier estimates and Cox propor-
tional hazards models for time-to-event analysis of sur-
vival. Analysis was performed using SAS 9.2 software (SAS
Institute, Cary, NC).
RESULTS
Patient demographics and preoperative character-
istics. Late failure contiguous with a prior infrarenal
aortic repair was identiﬁed in 158 patients. Of those re-
pairs, 104 occurred after an initial OSR at a mean time
of 10.8 years after the primary procedure, and these
were previously reported.6 Failure after EVAR was iden-
tiﬁed in 54 patients at a mean time of 5.1 years, with
mean aneurysm size of 67 mm. Two of the 54 patients
underwent urgent repair and were excluded from the
detailed analysis.
The demographic variables and variables relating to the
primary and rescue procedures that were collected in this
analysis are reported in Table I. Patients requiring rescue
procedures were younger at the time of their primary inter-
vention (72.3 vs 74.4 years; P ¼ .04) and more likely to
have chronic renal insufﬁciency (P ¼ .05). Signiﬁcant nega-
tive relationships were observed between age at primary
procedure and time to failure, indicating that as age in-
creases, the time to failure decreases (P ¼ .005).
Characteristics of the primary endovascular proce-
dure. The primary repair was limited to the infrarenal aorta
in all patients and was performed in a nonurgent setting for
all but one patient. Bifurcated devices were used in all 52
patients, although in one patient an aortouniiliac device
was also implanted at a later date. Long-body devices
(>6 cm) were implanted in 25 patients and short-body
devices in 27 patients. Table II lists the details of the pri-
mary implants.
CT scans before the initial endovascular repair were
available for review for only seven patients. The devices
implanted in six of these seven patients did not comply
with instructions for use (IFU; Table III). Additional in-
terventions after the primary repair but before the index
rescue procedure described in this report were performedin 39% (21 of 52) of patients before referral. The etiology
of failure was related to a proximal neck issue in all pa-
tients, which manifested in many different ways, as detailed
in Fig 2.
Characteristics of the endovascular rescue proce-
dure. Custom-designed Zenith fenestrated or Zenith
branched grafts were used to perform endovascular rescue
in all 52 patients (Fig 2). Eight of these patients under-
went juxtarenal repair, 21 had a type IV thoracoabdominal
repair, and 23 had a type II or III thoracoabdominal
repair. Short-body initial grafts resulted in the use of
modiﬁcations to the bifurcation design (internal limbs) in
14 patients. The details of the operative procedures can be
seen in Fig 3.
Results of endovascular rescue procedures. Fenes-
trated endografts were successfully deployed in 44 of 52
Table III. Details of preprimary procedure computed tomography (CT) scans
Patient
Immediate
infrarenal neck
diameter, mm
Neck
length, mm
Change in diameter
15 mm below lowest
renal, %
Aortic diameter
at level of
SMA, mm
Infrarenal
aorta-to- aorta
at SMA ratio Conical neck
Neck
angulation >60
1 24 3 34 25 1 Yes No
2 32 17 9 32 1 No No
3 22 14 14 25 1.1 Yes No
4a 27 15þ 3 25 0.92 No Yes
5a 17 5.6 53 23 1.35 Yes No
6 23 11 20 28 1.2 Yes No
7 27 11.7 18 27 1 Yes No
SMA, Superior mesenteric artery.
aPatients with Zenith (Cook Medical, Bloomington, Ind) top stent detachment.
Fig 2. Details of modes of failure of infrarenal endovascular devices described in this report.
Fig 3. Details of the operative procedures.
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cessfully stented in 71 of 77 patients (92%). Six of the tech-
nical failures occurred as a result of an inability to gain
access into one of the target arteries. The other technical
issues related to dissection or rupture of a target artery
leading to loss of that artery (Table IV).
The mean volume of contrast used in the rescue pa-
tients was signiﬁcantly less than the control group (93
vs 140 mL; P ¼ .001). This remained signiﬁcant when
the rescue group was divided by group 3 repair (P ¼
.006) and group 4 repair (P ¼ .001). The mean ﬂuoros-
copy time was longer in the rescue group, but this was
not signiﬁcant (83.3 [SD, 40.5]) vs 75.8 [SD, 40.9]) mi-
nutes; P ¼ .071). The mean operative time was 296 mi-
nutes. This was signiﬁcantly longer than the
254 minutes in the control group (P ¼ .008) and
remained signiﬁcantly longer when adjusted for repair
type (P ¼ .026; Table V).
Long-body vs short-body devices. Operative time
was signiﬁcantly longer for procedures where the original
implant was a short-body device (279.8 vs 343.1 mi-
nutes; P ¼ .023). The difference in contrast volume,
operative time, or ﬂuoroscopy time was not signiﬁcant. Alltechnical failures occurred in patients with previous long-
body devices with suprarenal ﬁxation.
Mortality. The 30-day mortality rate was 3.8% (two of
52). The difference in the perioperative (30-day) survival
between the primary and rescue fenestrated groups was not
statistically signiﬁcant (3.8% vs 2.9%; P ¼ .66). Late death
occurred in 20 patients (38.5%), two of which were aortic-
related deaths. One patient died of a ruptured aneurysm
4 years after rescue. He was noted to have had an increase
in sac size postoperatively with a type II endoleak and had
undergone translumbar embolizations on two occasions.
His last imaging was 2 months before his death, and no
obvious endoleak was noted at that time. The second pa-
tient attended another institution with an aortoenteric ﬁs-
tula and infected endograft 19 months after rescue and
died of sepsis before intervention.
Perioperative morbidity. Renal insufﬁciency compli-
cated 10% (ﬁve of 52) of fenestrated rescue procedures,
with one patient requiring temporary dialysis and one patient
requiring permanent dialysis. The incidence of myocardial
infarction was 3.8% (two of 52). Respiratory failure occurred
in four patients, with no patients requiring a tracheostomy.
Further details are outlined in Tables VI and VII.
Table V. Comparisons of groups on continuous measures overalldadjusted for repair type
Factor No. Failed, mean (95% CI) Control, mean (95% CI) Ratio, mean (95% CI) P
Contrast volume, mL 937 87.93 (75.43-102.50) 129.65 (122.16-137.60) 0.68 (0.59-0.79) <.001
Fluoroscopy time, minutes 940 66.37 (57.71-76.34) 63.77 (60.46-67.26) 1.04 (0.91-1.19) .56
Blood loss, mL 907 493.90 (385.39-632.98) 603.81 (551.82-660.71) 0.82 (0.64-1.04) .10
Operating time, minutes 930 287.44 (260.24-317.50) 257.61 (248.02-267.56) 1.12 (1.01-1.23) .026
CI, Conﬁdence interval.
Table IV. Technical failures
Patient
Primary
endograft Technical issue Technical failure Outcome
1 Zenitha Loss of ability to torque device due to
bent steel cannula
Inability to access left renal artery Left renal artery occlusion.
No endoleak.
2 Talentb Loss of ability to torque device due to
stiffness of primary endograft
1. Unable to access right renal
artery
2. Left renal artery stented
through SMA fenestration
Right renal artery occlusion.
No endoleak.
3 Zenitha Left renal artery dissection Absence of ﬂow in left renal artery Loss of left renal artery
4 Zenitha Difﬁculty maneuvering graft within
proximal neck due to previously placed
Palmazc stent.
Unable to access celiac artery No endoleak.
No secondary intervention
required.
5 Zenitha Failure to cannulate right renal artery Loss of right renal arterydthought
to be already occluded
Loss of right renal artery
6 Ancured Right renal artery stented but
extravasation of contrast so
fenestration plugged
Loss of right renal artery Loss of right renal artery
7 Zenitha Previously stented left renal artery Inability to cannulate left renal artery Loss of left renal artery
8 Zenitha Inability to cannulate left renal Inability to cannulate left renal Loss of left renal artery
SMA, Superior mesenteric artery.
aCook Medical, Bloomington, Ind.
bMedtronic, Minneapolis, Minn.
cCordis, Miami Lakes, Fla.
dGuidant, Indianapolis, Ind.
Table VI. Morbidity and mortality
Variable Branched/fenestrated rescue, No. (%)
Mortality
Early 2 (3.8)
Late 20 (38.5)
Renal insufﬁciency 5 (9.6)
Temporary dialysis 1 (1.9)
Permanent dialysis 1 (1.9)
Myocardial infarction 2 (3.8)
Respiratory failure 4 (7.7)
Tracheostomy 1 (1.9)
Reintervention rate
Early 5 (10)
Late 9 (17)
Table VII. Endoleaks
Endoleak Fenestrated rescue
Patients requiring
reintervention
Type Ia 1 1
Type Ib 3 2
Type II 8 3
Type III 4 3
Type IV 0 0
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rescue procedure was performed in 29% (15 of 52) of pa-
tients treated with rescue fenestrated grafts (Table VIII).
Eight of these 15 secondary interventions (54%) were
attributable to persistent endoleaks (Table VII). Two
further patients had sac growth but declined interventiondue to ill health. One renal stent stenosis required rein-
tervention with angioplasty and stenting, and one supe-
rior mesenteric artery thrombosis required mechanical
thrombectomy and restenting.
DISCUSSION
When failure of OSR or endovascular aortic repair oc-
curs, the materials used in the repair and the aortic wall it-
self may both be culpable. Endovascular rescue procedures
can successfully be used to address primary endograft fail-
ure. This report provides details of our experience with
Table VIII. Details of secondary interventions
Etiology Early/late Indication for intervention Intervention
Endoleak
Type I or III Early Type III endoleak from celiac artery Celiac stent
Late Type Ia endoleak Proximal extension
Late Type 1b endoleak from right limb Distal extension
Late Type III endoleak from renal artery Renal stent
Type II Late Type II endoleak with aneurysm sac expansion Translumbar embolization 2
Late Type II endoleak with aneurysm sac expansion Translumbar embolization 2
Late Type II endoleak with aneurysm sac expansion Translumbar embolization
Renal artery hemorrhage Early Bleeding from renal artery Coil embolization of left renal artery
Thrombosis
Branch Early SMA thrombosis SMA thrombectomy and stenting
Limb Early Occlusion of right iliac limb Femorofemoral crossover bypass
Others Late Renal artery stenosis Angioplasty and stent
Early Infolding of proximal extension Palmaza stent
Late Brachial artery pseudoaneurysm Repair of same
Late Left groin abscess Incision and drainage
? Hematoma Evacuation of hematoma
SMA, Superior mesenteric artery.
aCordis, Miami Lakes, Fla.
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5.1 years after primary EVAR and was more likely in
younger patients or those with renal insufﬁciency. Endo-
vascular rescue was performed with a 30-day mortality of
3.8% (two of 52), and a technical success of 85% (44 of
52). The reintervention rate was 10% early in the postoper-
ative course and 17% in the late postoperative course.
Although such results may appear to be acceptable,
given the circumstances of the initial device failure and
compared with the risk and morbidity of explant, contrast
volume and operative time were both higher for rescue
compared with primary repair with a branched or fenes-
trated endovascular device. We thus believe that if failure
of an infrarenal primary procedure is predictable and a
more extensive primary procedure could be performed,
the long-term risk for some patients may be lower.
The design of the rescue device must be carefully consid-
ered because each patient and device conﬁguration poses
unique challenges. Long-term device durability, the potential
for migration, and the ability to achieve distal seal must all be
considered inaddition to the anticipatedchallengesofdelivery
and deployment. The body length of the primary prostheses
remains a relevant concern in the absence of an infrarenal
neck where a fenestrated/branched device must be placed.
For patients with juxtarenal aneurysms, where the aorta has
a normal caliber through the visceral segment, migration be-
tween the primary and rescue device is less likely, so less over-
lap between devices may be sufﬁcient. However, the
treatment of visceral-segment aneurysms above a previous
infrarenal device would require the same 6 to 7 cm of overlap
recommended for primary branched/fenestrated procedures
for distal stabilization. If this overlap cannot be achieved
within the primary implant, then we use fenestrated devices
coupledwithabifurcateddevicewithan internal limb,moving
the overlap portion of the repair into the two limbs.
Although endovascular rescue procedures are feasible,
operative time is longer, device design is complex, andtechnical success is less common. This higher operative
risk, coupled with the interim risk of rupture between
the primary and rescue procedure, points to a need to bet-
ter identify good infrarenal vs fenestrated candidates
before the primary procedure. The inability of current im-
aging techniques to distinguish between healthy and
diseased tissue in an aorta with a normal caliber, coupled
with the understanding of the aortic aneurysm as a sys-
temic vessel wall disease, means that current treatment ap-
proaches only deal with the portion of disease that is
visible, which implies the possibility of progressive aortic
disease in the future. CT scans before the primary
EVAR were available for review in only seven of 49 pa-
tients. The proximal neck morphology in six of seven pa-
tients did not ﬁt the IFU for the primary endograft. There
is reasonable evidence to suggest that EVAR implantation
outside of recommended IFUs is associated with an
increased rate of late failure.17
Patients requiring an endovascular rescue procedure
were younger at the time of their primary intervention
(P ¼ .04) and were more likely to have a history of renal
insufﬁciency (P ¼ .005) compared with patients treated
for similar aneurysms. These data are similar to the ﬁndings
of our recent publication, detailing rescue of OSR by endo-
vascular means.6 In the later series, patients developing fail-
ure underwent their initial repairs at a younger age (61.4
[SD, 10.0] vs 74.1 [SD, 9.6] years; P < .00001) and, inter-
estingly, were more likely to have a family history of aneu-
rysmal disease (20% vs 7%; P ¼ .001). The combination of a
young age and a family history of aneurysmal disease ap-
pears to be indicative of more extensive underlying long-
term aortic degeneration. However, the knowledge that
the residual aorta in this patient group is potentially vulner-
able leaves us with a difﬁcult clinical conundrum: to treat
longer segments of aorta with the knowledge that the risk
of complications, such as spinal cord ischemia and coagul-
opathy, may be higher than in a lesser repair.14,18
Fig 4. Three-dimensional reconstructions show failed endovascular repairs and the conﬁguration of fenestrated devices
used for rescue in a (A and B) long-bodied and (C and D) short-bodied device.
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in those with renal insufﬁciency. Although renal insufﬁ-
ciency is reported in up to 25% of patients with abdominal
aortic aneurysms,19 its association with increased failure of
primary EVAR has not been reported. We do not have in-
formation pertaining to the renal function of these patients
before their primary procedure. We hypothesize that the
etiology of the renal insufﬁciency in this cohort of patients
is likely multifactorial. All of these patients would have
had a series of contrast CT scans in follow-up, and in addi-
tion, 21 of 52 patients had at least one endovascular rein-
tervention before their rescue procedure, exposing them
to a further contrast load.
The choice of endovascular rescue procedures over
alternatives, such as conversion to OSR or medical man-
agement, merits some discussion. The recent long term
follow-up from the Comparison of Endovascular Aneurysm
Repair with Open Repair in Patients with Abdominal
Aortic Aneurysm (EVAR-1) trial, which demonstrated
late rupture in 25 patients with a mortality rate of 75% in
this group, illustrates that medical palliation should be
held as an option for only those patients who are truly unﬁt
for any reintervention.5 Late surgical conversion and aortic
reconstruction is associated with a reasonably high mortal-
ity rate in the setting of infrarenal disease and with an even
greater risk when the disease involves the visceral segment.7The feasibility of using an endovascular approach to
manage endograft failure must be independently explored
for each patient. Factors affecting candidacy include
anatomic features of the aneurysm and the choice of the
previous endograft, along with subsequent bailout at-
tempts (balloon-expandable stents within the neck, renal
stents, and the management of iliac issues).
When failure of an EVAR is noted, the placement of
large amounts of radiopaque material diminishes diagnostic
capabilities and complicates rescue procedures. In addition,
accurate implantation of a fenestrated device requires not
only precise longitudinal positioning but also the ability to
torque the device (rotational control). This becomes much
more difﬁcult when the fenestrated component is advanced
through a tortuous endograft. These factors resulted in tech-
nical failures in six of the 52 fenestrated patients. One of
these patients required an additional procedure to occlude
a fenestration that was unable to bemated with the intended
target artery simply to prevent endoleak, with a further
patient requiring permanent dialysis after the procedure.
Early conduit creation may alleviate some of these issues,
yet increases perioperative risks. The best way to improve
rescue procedures is to optimize the primary repair.
The body length of the primary implant should also be
considered (Fig 4). The type and distribution of endografts
in the index procedure in this report reﬂects our conﬁdence
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repair rather than the distribution of devices presenting
with failure. The higher proportion of Cook devices in
this cohort reveals our initial bias that these were ideal de-
vices, because of their long body and relative ease of rein-
tervention, in which to perform a rescue procedure.
Short body lengths complicate any future bailouts by
diminishing the ability to overlap devices and force the
coupling of a fenestrated/branched device with a bifur-
cated device with an internal limb rather than the use of
a single device, and the operative time for repair of this
group in our series was signiﬁcantly longer than for the
long-body devices (P ¼ .02).
The design of rescue devices for patients who have
been implanted with a long-body primary device is more
straightforward because distal seal can be achieved in the
old long-body device. However, all of our technical failures
occurred in patients whose primary repair was with a long-
body device with suprarenal ﬁxation, and the endoleak rate
after the procedure was signiﬁcantly higher in this group
(P ¼ .04). The presence of suprarenal uncovered stents
was not highlighted by our surgeons as a factor that
compromised technical success; however, the loss of the
ability to torque the fenestrated device within a stiff long-
body device should not be underestimated. The technical
difﬁculties associated with these procedures have been
noted in smaller series.20
Our study has several limitations. In only a small per-
centage of the patients undergoing rescue procedures was
the initial surgery performed at our institution. Despite
several attempts to obtain the imaging before and after
the initial endograft implantation, this was largely unsuc-
cessful, which hampered our ability to determine the ade-
quacy of the initial procedure and the timing of the
failure. This, compounded by the fact that our series is rela-
tively small, makes it difﬁcult to reach conclusions
regarding the features that might predispose to failure.
Finally, considerable device evolution occurred during
the course of the treatment of these patients. Improve-
ments in delivery systems, methods of target vessel cannu-
lation, and mating technology will likely improve overall
outcomes. However, from an engineering standpoint,
rescue procedures are very complex to evaluate. Few data
are available pertaining to the overlapping of one type of
endograft to another, particularly over short distances or
when other adjuncts (cuffs, balloon-expandable stents, or
coils) have been used at the interface.
CONCLUSIONS
The concept that aortic disease is a systemic disease
that permits aneurysm formation in a metachronous
manner rather than affecting one segment in isolation man-
dates a new planning strategy for its treatment. Our ﬁnd-
ings suggest that groups with a tendency to fail,
including younger patients and patients with a family his-
tory of aneurysms, must have a primary repair performed
that would more easily permit a rescue procedure should
it be necessary in the future. The design of the primaryendograft, particularly in this cohort of patients, should
take into account the potential need for further treatment.
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